Drugs / IDA
last change Dec 2018 re-read 2 minutes ago

IDA

Developed for
acute promyelocytic leukemia

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01226303 Comparator Jan 2009 → Jun 2017 acute promyelocytic leukemia Italian Association of Pediatric Hematology and Oncology Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as IDA ClinicalTrials.gov intervention name — accepted as the source's own label NCT01226303